WallStSmart

Coca-Cola European Partners PLC (CCEP)vsVita Coco Company Inc (COCO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola European Partners PLC generates 3328% more annual revenue ($20.90B vs $609.78M). COCO leads profitability with a 11.7% profit margin vs 9.3%. CCEP trades at a lower P/E of 18.7x. CCEP earns a higher WallStSmart Score of 59/100 (C).

CCEP

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 6.5Value: 7.3Quality: 5.5
Piotroski: 3/9Altman Z: 1.55

COCO

Hold

49

out of 100

Grade: D+

Growth: 9.3Profit: 7.0Value: 6.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCEPUndervalued (+57.7%)

Margin of Safety

+57.7%

Fair Value

$230.72

Current Price

$93.23

$137.49 discount

UndervaluedFair: $230.72Overvalued
COCOOvervalued (-5.9%)

Margin of Safety

-5.9%

Fair Value

$55.69

Current Price

$53.87

$1.82 premium

UndervaluedFair: $55.69Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP3 strengths · Avg: 9.0/10
EPS GrowthGrowth
68.3%10/10

Earnings expanding 68.3% YoY

Return on EquityProfitability
22.9%9/10

Every $100 of equity generates 23 in profit

Free Cash FlowQuality
$1.51B8/10

Generating 1.5B in free cash flow

COCO3 strengths · Avg: 9.7/10
Revenue GrowthGrowth
40.0%10/10

Revenue surging 40.0% year-over-year

EPS GrowthGrowth
75.6%10/10

Earnings expanding 75.6% YoY

Return on EquityProfitability
24.2%9/10

Every $100 of equity generates 24 in profit

Areas to Watch

CCEP4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.2%4/10

0.2% revenue growth

Altman Z-ScoreHealth
1.554/10

Distress zone — elevated risk

Debt/EquityHealth
1.503/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

COCO3 concerns · Avg: 2.7/10
Price/BookValuation
9.3x4/10

Trading at 9.3x book value

P/E RatioValuation
46.0x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-7.12M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on EPS Growth, Return on Equity, Free Cash Flow.

Bull Case : COCO

The strongest argument for COCO centers on Revenue Growth, EPS Growth, Return on Equity. Revenue growth of 40.0% demonstrates continued momentum.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : COCO

The primary concerns for COCO are Price/Book, P/E Ratio, Free Cash Flow. A P/E of 46.0x leaves little room for execution misses.

Key Dynamics to Monitor

CCEP profiles as a value stock while COCO is a growth play — different risk/reward profiles.

CCEP carries more volatility with a beta of 0.39 — expect wider price swings.

COCO is growing revenue faster at 40.0% — sustainability is the question.

CCEP generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

CCEP scores higher overall (59/100 vs 49/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

Vita Coco Company Inc

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Vita Coco Company, Inc. develops, markets, and distributes coconut water products under the Vita Coco brand in the United States, Canada, Europe, the Middle East, and Asia Pacific. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?